Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health. 2023;11(2):e197–206.
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. The Lancet Global Health. 2019.
Global Burden of Disease Cancer C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.
Ngcobo N, Jaca A, Iwu-Jaja CJ, Mavundza E. Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination. Curr Opin Immunol. 2021;71:21–6.
Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021;9(2):e161–9.
Eze JN, Emeka-Irem EN, Edegbe FO. A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria. Clin Med Insights Oncol. 2013;7:151–8.
Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters. 2008;16(32):41–9.
Maranga IO, Hampson L, Oliver AW, Gamal A, Gichangi P, Opiyo A, et al. Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS ONE. 2013;8(10): e78411.
Musa J, Nankat J, Achenbach CJ, Shambe IH, Taiwo BO, Mandong B, et al. Cervical cancer survival in a resource-limited setting-North Central Nigeria. Infect Agent Cancer. 2016;11:15.
Organization WH. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: World Health organization; 2020.
Shah S, Xu M, Mehta P, Zetola NM, Grover S. Differences in outcomes of chemoradiation in women with invasive cervical cancer by human immunodeficiency virus status: a systematic review. Pract Radiat Oncol. 2021;11(1):53–65.
Tebeu PM, Ngou-Mve-Ngou JP, Zingue LL, Antaon JSS, OkobalembaAtenguena E, Dohbit JS. The pattern of cervical cancer according to HIV status in Yaounde, Cameroon. Obstet Gynecol Int. 2021;2021:1999189.
Glasmeyer L, McHaro RD, Torres L, Lennemann T, Danstan E, Mwinuka N, et al. Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting. BMC Cancer. 2022;22(1):892.
Trejo MJ, Lishimpi K, Kalima M, Mwaba CK, Banda L, Chuba A, et al. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia. Int J Gynecol Cancer. 2020;30(5):613–8.
Nissim O, Dees A, Cooper SL, Patel K, Lazenby GB. Cervical cancer among women with HIV in south Carolina during the era of effective antiretroviral therapy. J Low Genit Tract Dis. 2022;26(2):109–14.
Federal Ministry of Health N. National Guidelines for HIV Prevention Treatment and Care. In: Programme NAaSC, editor. 2020.
Matsuo K, Machida H, Mandelbaum RS, Konishi I, Mikami M. Validation of the 2018 FIGO cervical cancer staging system. Gynecol Oncol. 2018.
Silas OA, Abdulkareem F, Novo JE, Zheng Y, Nannini DR, Gursel DB, et al. Telepathology in Nigeria for global health collaboration. Ann Glob Health. 2022;88(1):81.
Lombe D, M’Ule BC, Msadabwe SC, Chanda E. Gynecological radiation oncology in sub-Saharan Africa: status, problems and considerations for the future. Int J Gynecol Cancer. 2022;32(3):451–6.
Semeere A, Freeman E, Wenger M, Glidden D, Bwana M, Kanyesigye M, et al. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa. BMC Cancer. 2017;17(1):611.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.
Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria: R Foundation for Statistical Computing, Vienna, Austria; 2022. https://www.R-project.org/.
Odukoya O, Nenrot D, Adelabu H, Katam N, Christian E, Holl J, et al. Application of the research electronic data capture (REDCap) system in a low- and middle income country- experiences, lessons, and challenges. Health Technol (Berl). 2021;11(6):1297–304.
Sjoberg DDWK, Curry M, Lavery JA, Larmarange J. Reproducible summary tables with the gtsummary package. R J. 2021;13:570–80.
T T. A Package for Survival Analysis in R. R package version 3.3-1 ed2022.
Kassambara A KM, Biecek P. (2021). _survminer: Drawing Survival Curves using ‘ggplot2’. R package version 0.4.9 ed2021.
Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, Efstathiou JA, Grover S, Chiyapo S, et al. HIV infection and survival among women with cervical cancer. J Clin Oncol. 2016;34(31):3749–57.
Grover S, Mehta P, Wang Q, Bhatia R, Bvochora-Nsingo M, Davey S, et al. Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV. J Acquir Immune Defic Syndr. 2020;85(2):201–8.
Musa J, Achenbach CJ, Evans CT, Jordan N, Daru PH, Silas O, et al. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis. Infect Agents Cancer. 2019;14(1):43.
Gizaw M, Addissie A, Getachew S, Ayele W, Mitiku I, Moelle U, et al. Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study. Infect Agent Cancer. 2017;12:61.
Awolude OA, Oyerinde SO. Invasive cervical cancer in Ibadan: socio-sexual characteristics, clinical stage at presentation, histopathology distributions and HIV status. Afr J Infect Dis. 2019;13(1):32–8.
Nicolas-Parraga S, Alemany L, de Sanjose S, Bosch FX, Bravo IG, RisHpv TT, et al. Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma. Int J Cancer. 2017;140(9):2092–100.
Add Comment